Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

FDA Product

NAFCILLIN SODIUM

Product approved by U.S. Food and Drug Administration (US)

Basic Information

Product Name

NAFCILLIN SODIUM

FDA Product Code

82449-503

Regulatory Information

NDC Product Code

82449-503

Application Number

ANDA200002

Marketing Category

C73584

Effective Date

October 17, 2023

Territorial Authority

USA

FDA Title

Nafcillin for Injection, USP For Intramuscular or Intravenous Injection

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Version Number

1

Company Information

ManufacturerSteriscience Specialties Private Limited

DUNS Number

853179150

Active Ingredients

NAFCILLIN SODIUM

Quantity: 1 g in 1 1

Code: 49G3001BCK

Class Code: ACTIM

Inactive Ingredients

SODIUM CITRATE

Code: 1Q73Q2JULR

Class Code: IACT

Active Moieties

NAFCILLIN

Code: 4CNZ27M7RV

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy